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Abstract
Mechanical loading is essential for maintaining bone tissue. Reduced mechanical loading
has been shown to have a negative effect on bone, and can result in the development of disuse
osteoporosis. Disuse models of muscle inactivity and immobilization, like the Botox model used
in this study, result in changes in the bone microarchitecture, the mechanisms behind which
are not fully understood. In a previous four-week Botox disuse study, skeletally mature 20week-old rats experienced degradation of intracortical bone, increased vascular porosity, and
decreased osteocyte lacunar density in the tibiae. The focus of this study was to explicate a
potential source of these differences and determine if changes in gait, muscle gene expression,
and markers of osteocyte activity could be detected as early as one week after Botox-induced
muscle paralysis. In the present study, 20-week-old female rats were injected with botulinum
toxin A (BTX, n=12) in the right hindlimb muscles, while external control rats (CTRL, n=12) were
similarly injected using a saline solution. Animals then underwent gait and digit analyses to
quantify the degree of paralysis. One-week post-injection, osteocyte expression of sclerostin
(Scl), osteocyte apoptosis (caspase-3), perilacunar remodelling (cathepsin K), and staining of
vascular pores and mast cells were assessed using immunohistochemistry. Real-time polymerase
chain reaction (qPCR) was performed on the quadriceps muscles to assess relative expression
differences for several musculoskeletal-related genes (Tgf-β1, Mstn/Gdf-8, Fgf-2, and Igf-1).
After one week of disuse, Botox-injected rats had a decrease in gait ability of ~75% and
decreased digit abduction. Quadriceps and calf muscles showed a significant reduction in
muscle mass (>20%) in the BTX group compared to CTRL. While there were only a few localized
iii

changes in osteocyte activity, the muscle relative genetic expression analysis showed increased
relative gene expression of myostatin in BTX left versus BTX right (injected) and both CTRL
limbs, indicating a potential systemic effect of Botox and/or disuse.
Keywords: Muscle, Botox, Disuse, Osteocyte, Bone
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1. Introduction
1.1 Bone and the Skeletal System
The skeletal system is composed of several tissues, including bone, cartilage, ligaments,
and tendons, and its functions are mainly mechanical in nature. Bone, which makes up the
largest portion of the system by mass, is a highly mineralised and hard tissue that can adapt
and remodel throughout a lifetime due to bone turnover. Bone provides structural support (to
allow for movement through muscle attachment points) and protection from trauma injuries;
it also houses marrow tissue that is responsible for producing blood and stem cells, and serves
as a calcium reserve for various biological processes [Ethier and Simmons 2007, Feng 2009,
Robey and Boskey 2013]. What differentiates bone from other connective tissues besides its
ability to regenerate over time is its composition.

1.2 The Composition of Bone
Bone is a composite whose extracellular matrix (ECM) can be split into two constituents:
water (5-10 percent [Clarke 2008]) and solids, which are typed as organic and inorganic. The
inorganic portion of bone is made of the mineral hydroxyapatite [Schlesinger et al. 2020]. The
organic solids are mainly ~90 percent collagen type I, ~5 percent non-collagenous proteins (such
as large proteoglycans, metalloproteases, osteocalcin, osteopontin, osteonectin, etc.), and ~2
percent lipids [Boskey 2013, Carvalho et al. 2021]. The exact percentages for all these materials
are dependent upon age, species, medications, genetics, and the anatomical site. The
components of bone have both mechanical and metabolic functions, which have been
determined over time using in vivo animal models as well as in vitro analyses of healthy and
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diseased human tissues and from cell culture studies [Burr et al. 2002, Wallace et al. 2006,
Nyman et al. 2006].

Inorganic Bone Matrix Components
The inorganic solids make up approximately 70 percent of bone mass and are primarily
composed of the highly substituted analogue of the naturally occurring hydroxyapatite
(Ca5(PO4)3(OH)) that has a nano-crystalline structure, amongst other smaller minerals [Ethier
and Simmons 2007, Boskey 2013]. The mineralization of bone takes place over multiple steps;
5-10 days after the ECM is deposited, primary mineralisation occurs when hydroxyapatite starts
to become incorporated—this process then slows and secondary mineralisation starts with an
increased number and size of hydroxyapatite crystals being deposited [Licini et al. 2019]. The
inorganic portion adds mechanical resistance to bone by integrating itself throughout the
collagen fibres during development and healing. In addition, the mineral also serves as a
homeostatic repository for calcium, phosphate, and magnesium ions [Robey and Boskey 2013].

Collagen
The organic phase of bone tissue is made up of mostly type I collagen (Col1) and contains
minute amounts of collagen types III and V (Col3 and Col5, respectively), and even smaller
amounts of Fibril-Associated Collagens with Interrupted Triple Helices (FACIT) [Clarke 2008].
The role of Col1 is to provide a scaffolding where proteins that nucleate, or initiate, the
formation of hydroxyapatite deposition [Clarke 2008, Robey and Boskey 2013]. FACIT fibrils are
non-fibrillar collagen that help with stabilising and systematising the ECM [Shaw and Olsen 1991,
Ivanova and Krivchenko 2014].

Bone Cells
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Throughout life, bone undergoes maintenance in order to best sustain its functional
ability. This task is orchestrated by the bone cells that live inside the system, which are
osteoblasts, osteoclasts, osteocytes, and bone lining cells.
Osteoblasts
Osteoblasts make up 4-6 percent of the bone cell population [Capulli et al. 2014] and
are considered the builders in bone, where their role is to synthesise and lay down the collagen
and non-collagenous proteins of the organic matrix, and to promote hydroxyapatite formation
through enzymatic secretions [Palmer et al. 2008]. These cells differentiate from a
mesenchymal stem cell lineage, where the expression of the transcription factors runt-related
transcription factor-2 (Runx2), distal-less homeobox-5 (Dlx5), and msh homeobox homologue-2
(Msx2), and Osterix (Osx) are required to initiate these precursor cells progression toward the
osteoblast lineage, and not the other cell types descending from this lineage (adipocytes,
myocytes, and chondrocytes) [Robling et al. 2006, Zhang 2010]. The Wnt/β-catenin pathway
then controls the osteoblasts’ proliferation, maturation, terminal differentiation, and plays a
role in bone formation [Clarke 2008, Bonewald and Johnson 2008, Saidak et al. 2015].
Osteoblasts present in the bone marrow also secrete macrophage colony-stimulating
factor (M-CSF) and receptor activator of NF-κB ligand (RANKL), which are required for
osteoclastogenesis [Clarke 2008]. Differentiated osteoblasts (and osteocytes) also produce
Dickkopf (Dkk1) and sclerostin (Scl), which are Wnt inhibitor proteins that control osteoblast
differentiation and function through a negative feedback loop. In addition, Wnt signalling
promotes osteoblastic production of osteoprotegerin (OPG). OPG is a soluble competitor
molecule for RANKL, and that inhibits the activity of RANKL to reduce osteoclastogenesis by
competitively binding to RANK receptors on both precursor and mature osteoclasts [Robling et
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al. 2006]; by increasing the ratio of OPG to RANKL, osteoclast differentiation and bone
resorption is decreased.
Osteoclasts
Osteoclasts are multinucleated cells from macrophage lineage in the bone marrow and
act opposite to osteoblasts, where their recruitment is done to resorb—or dissolve—bone [Ethier
and Simmons 2007]. Making up a very small percentage of the bone cell population in the body,
osteoclasts are rarely found in bone with only two to three found per cubic micron [Roodman
1996]. Despite their small population, they play a major role in bone maintenance, where they
are involved in skeletal development, calcium metabolism, and remodelling [Li et al. 2006]. As
aforementioned, osteoclastogenesis requires bone marrow osteoblasts to produce two
cytokines: RANKL and M-CSF. RANKL belongs to the TNF superfamily and is critical for osteoclast
formation. Osteoclast precursors require M-CSF for proliferation, survival, and differentiation,
where it then is required for osteoclast survival and cytoskeletal rearrangement that occurs
during bone resorption [Clarke 2008, Cheng and Fong 2014].
For bone to be resorbed, osteoclasts that are in the bone marrow migrate to the
resorption site, where the cell membranes then become polarized while transitioning from the
motile to resorption status [Lakkakorpi and Väänänen 1996, Li et al. 2006]. The osteoclast
reorganizes its cytoskeleton and polarizes through non-canonical Wnt signalling [Uehara et al.
2018], into an actin ring as the cell binds to the bone matrix via integrin attachment to bone
matrix peptides, the most common being RGD [Feng 2009]. Osteoclast membranes contain the
β1 family of integrin receptors that bind to collagen, fibronectin, and laminin; however, the
main receptor for resorption is the αvβ3 integrin, which binds to osteopontin and bone
sialoprotein [Ross and Teitelbaum 2005]. The actin ring (sealing zone) is the osteoclast
attachment to the matrix, and it isolates the area and prevents protons and other resorptive
4

proteolytic enzymes from going into the surrounding bone outside the ring. Within the sealing
zone, the cell membrane in contact with the bone is referred to as the ruffled border and it
secretes tartrate resistant acid phosphatase (TRAP), and cathepsin K, and hydrogen ions (H+)
[Li et al. 2006, Clarke 2008, Nakayama et al. 2011]. TRAP assists in bone resorption by degrading
skeletal phosphoproteins, including osteopontin (OPN) [Hayman 2008, Robling et al. 2006] and
is an indicator of polarized osteoclasts [Nakayama et al. 2011]. By secreting H+ ions, osteoclasts
can increase the acidity of the environment within the sealed border to dissolve the mineral
component of bone matrix. Lastly, cathepsin K digests the type I collagen in the matrix [Li et
al. 2006, Clarke 2008].
Osteocytes
Osteocytes make up 90-95 percent of the population of cells in bone and are mature
osteoblasts that after being trapped within the matrix secreted by other osteoblasts,
permanently reside in in small cavities, or lacunae, that are connected through a network of
canals called canaliculi [Ethier and Simmons 2007, Robey and Boskey 2013, Franz-Odendaal et
al. 2006, Florencio-Silva et al. 2015]. Osteocytes are considered to be the mechanosensory cells
of bone that process input signals from interstitial fluid flowing in this network, which is
referred to as the lacunar-canalicular system (LCS). Within the LCS, osteocytes receive
nutrients dissolved in the extracellular fluid. Osteocytes are believed to play a role in the
maintenance of bone tissue by monitoring and responding to fluid flow in the local
microenvironment [Fritton and Weinbaum 2009]. These cells can communicate with lining cells
(detailed below) and other osteocytes through the LCS. Additionally, osteocytes are also
thought to be able to communicate with osteoblasts via cytoplasmic processes that extend
through gap junctions into the osteoid matrix [Civitelli 2008, Moreira et al. 2019].

5

Bone Lining Cells
Bone lining cells make up the small remaining percentage of cells and can be found on
the surfaces of bone [Ethier and Simmons 2007, Robey and Boskey 2013]. Though the exact
purpose of lining cells has not been fully defined, studies have shown they are linked to
osteoclast differentiation (they produce OPG and RANKL) and also prevent osteoclasts from
resorbing bone where it is not necessary [Florencio-Silva et al. 2015]. When needed, these cells
can also differentiate into osteoblasts [Johannesdottir and Bouxsein 2019].

Water
Much like bone lining cells, the role of bound water in the mineral portion of bone has
not been completely defined; however, it is thought to play a role in aggregating the apatite
crystals in the matrix and providing structural support [Granke et al. 2015]. Free water has
been shown to fill pores, interact with collagen fibrils, and bind to mineral crystals, where its
presence (or absence) influences mechanical properties in bone (i.e., ductility, plasticity, etc.)
[Yoder et al. 2012, Granke et al. 2015].

1.3 Types of Bone
There are two types of bone, which are classified by their microstructure and apparent
density: cortical and cancellous bone.

Cortical Bone
Cortical bone, which is also referred to as compact bone, is the outer layer of most
bones. Of the two bone types, cortical bone has a lower porosity (less than 10 percent), greatly
impacting its mechanical properties and causing it to be stronger and stiffer than cancellous
bone. When cortical bone is being formed, it is laid down in layers that are approximately 3-7
6

µm thick called lamellae [Bromage et al. 2009]. Within each lamella, the collagen fibres are
parallel to one another; however, this orientation is not the same in the adjacent layers, where
they are rotated to create a plywood-like structure [Mitchell and Heteren 2016].

Cancellous Bone
Cancellous bone is also referred to as trabecular, or spongy bone, and is typically found
in vertebrae and at the ends of long bones (i.e., ulna, tibia, femur, etc.). While cortical bone
is markedly dense in comparison to cancellous bone, the porous—hence spongy—nature of
cancellous bone allows for shock absorption during movement (mechanical loading). The lattice
structure is formed by bone arranged into connected plates and rods called trabeculae. Despite
the difference in appearance, cancellous bone also has a lamellar structure, where the lamellae
are arranged parallel to the trabeculae [Ethier and Simmons 2007, Stauber et al. 2006].

1.4 Bone Adaptation and Mechanical Loading
Bone is a dynamic tissue that can modify itself in response to the mechanical
environment it is subjected. Normal anatomy can resist breaking or extensive damage during
physiological loading or overloading (to a point) due to this trait.

Mechanotransduction
According to Wolff’s law, bone alters its microarchitecture in response to the strains
experienced

during

different

activities

(physiological

loading,

strenuous

exercise,

immobilization, etc.) [Wolff 1892]. Further developing this theory, Frost proposed that
adaptation is the result of bone manipulating its strength in order to keep the resulting strain
from physiological loads within a close-set point range [Frost 1994]. Comparing both theories,
mechanical loading would then be the most important determinant of bone strength. Also, as
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bone is metabolically expensive for the body to maintain—if there is too much of it for the
amount of load experienced by the body, it will undergo remodelling to remove it (catabolic)
whereas bone formation (anabolic) will occur if there is too little [Robling and Turner 2009].
Bone is well known to adapt to its mechanical environment through the process of
mechanotransduction, where mechanical loading is transduced by osteocytes into cellular
responses to maintain bone tissue [Fritton and Weinbaum 2009]; it is the process by which these
cells convert mechanical forces into biological signals [Burger and Klein Nulend 1999,
Temiyasathit and Jacobs 2010]. Mechanotransduction is dependent on external gravitational
forces acting on the system and endogenous muscle forces; proper loading is required for both
the development and maintenance of bone. Mechanical loading is one of the sources of
signalling to induce bone regulation and turnover [Robling et al. 2009] and depending on the
type of loading, osteocytes respond in either anabolic or catabolic ways.

Osteocytes and the Lacunar-Canalicular System (LCS)
Small deformations of the bone matrix caused by cyclic loading produce a pulsatile fluid
flow within the LCS, allowing for the transport of cell signalling molecules, nutrients, and waste
products to and from osteocytes and other cells within the bone matrix by connecting to
vascular pores [Fritton and Weinbaum 2009]. In addition, these deformations cause strains
within the system, which both activate osteocytes within the area and maintain osteocyte
viability due to the fluid flow [Dallas et al. 2013, Klein-Nulend et al. 2013]. The mechanical
activation of osteocytes from physiological strains results in the release of factors, such as bone
morphogenetic proteins (BMPs), Wnts, prostaglandin E2 (PGE2), NO, and RANKL [Klein Nulend et
al. 2012, Robling and Bonewald 2020], leading to subsequent bone formation or remodelling by
controlling the recruitment, differentiation, and activity of osteoblasts and osteoclasts [Burger
and Klein Nulend 1999, Hughes and Petit 2010]. Conversely, when mechanical stimuli strain
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magnitudes repeatedly fall below a certain threshold, osteocyte apoptosis occurs, followed by
bone resorption. Studies have shown that osteocyte apoptosis results in bone turnover in
microdamage accumulation and disuse conditions [Seref-Ferlengez et al. 2015, Herman et al.
2010, Gross et al. 2010, Burr and Martin 1993, Burr et al. 1985], demonstrating the pivotal role
osteocytes have in the maintenance of bone. Osteocytes are also thought to monitor signals
through the primary cilia, which are microtubule-based rigid structures that extend from the
basal body into the extracellular space, where they have been shown to be mechanosensors in
liver and kidney studies [Temiyasathit and Jacobs 2010, Spasic and Jacobs 2017]. Though mostly
studied during skeletal development in bone, several studies have shown that primary cilia have
also been observed to affect bone homeostasis [Kwon et al. 2008, Xiao et al. 2010, Malone et
al. 2007, Temiyasathit et al. 2012, Leucht et al. 2013]. The study by Malone et al. demonstrated
the signalling pathway within bone was independent from intracellular calcium, implying that
the primary cilia mechanotransduction signalling pathway is different from its normal pathway
in kidney and is bone specific.

1.5 Skeletal Muscle
Muscle is subdivided into three types: skeletal, smooth, and cardiac. These muscles can
then be categorised by their fibre types, which can either be striated (skeletal and cardiac), or
smooth. Skeletal muscle, which will be the focus of this paper, is voluntarily controlled. In
addition, the mass of muscle depends on the balance between protein synthesis and
degradation. This balance is highly affected by diet and nutrition, physical activity/exercise,
hormonal balance, injury or disease, and genetics [Frontera and Ochala 2015, Laurent et al.
2016].
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Composition and Function
Skeletal muscle is an extremely organised structure composed primarily of contractile
material as well as connective tissue, blood vessels, and nerves, and it makes up approximately
40% of the total body weight [Silverthorn 2013, Gillies and Lieber 2011, Frontera and Ochala
2015]. The contractile material is made from muscle fibres, or myofibers, which are very
structured and almost crystalline-like pattern of contractile and elastic protein bundles
(myofibrils) with their long axes arranged in parallel [McNally et al. 2006]. Myofibers are formed
by mononuclear myoblasts fusing to create a multinucleate syncytium, allowing for better
coordination when responding to neural inputs when movement is initiated [McNally et al.
2006]. The myofibrils are wrapped in a lace-like structure called the sarcoplasmic reticulum
(SR), which functions to sequester intracellular calcium for use during contractile events. The
myofibers themselves are covered in a connective tissue, then bundled into fascicles. The other
constituents of the muscle can be found in between the fascicles [Silverthorn 2013].
Myofibrils are composed of contractile proteins (myosin and actin), regulatory proteins
(tropomyosin and troponin), and large accessory proteins (titin and nebulin). Myosin is an
important protein that determines the muscle type and speed of contraction (fast twitch versus
slow titanic twitch [McNally et al. 2006]) and composes the thick filament of the skeletal
muscle; it contains a binding site for ATP, where the energy from breaking its phosphate bond
is used for movement, and also one for actin. Actin composes the thin filament of the myofibril.
The two filament types are arranged together in a repeating pattern, where one unit is called
the sarcomere. Titin and nebulin are responsible for ensuring proper alignment of the filaments,
where titin’s high elasticity helps return muscles to their resting length, and nebulin’s
inelasticity specifically helps to keep actin aligned properly [Silverthorn 2013]. The regulatory
proteins are used for initiating muscle contractions, where the binding of calcium from the SR
(caused by acetylcholine being released by the somatic motor neuron in the muscle, which in
10

turn initiates an action potential) to troponin removes tropomyosin from blocking actin’s myosin
binding site and contraction can then occur [Silverthorn 2013].
Metabolically, skeletal muscle also serves as a reserve for amino acids and carbohydrates
for use by other tissues like the skin, heart, and brain for inputs in the production of their
specific proteins, and for heat production to maintain body temperature [Wolfe 2006].

1.6 The Muscle-Bone Unit
Muscle and bone are two of the primary components of the musculoskeletal system that
allow for locomotion. The inorganic portion of the bone matrix acts as a rigid lever, acting as
an anchor for muscles, by providing mechanical resistance, all while remaining as light as
possible to prevent hampering movement [Turner 1998]. As muscles contract, they pull against
the skeleton and forces are generated, exposing bone to various stimuli [Turner 1998,
Tagliaferri et al. 2015]. The organic portion of the bone matrix resists tension, providing
mechanical resistance to muscle contraction [Creecy et al. 2021]. Depending on the type of
muscle contraction (i.e., low/high frequency, isometric, static, etc.), the forces generated can
vary depending on the activity [Maurel et al. 2017]. As the attachment sites of muscles are
close to the axes of motion, a lever arm is produced on the bone [Avin et al 2015.]. It is then
thought that these muscle-derived forces (mechanical loads) are transferred into the bone,
where they serve as the source that produces strain. In addition to muscle-generated forces,
gravitational and ground reaction forces from impact loading also play a role in bone
maintenance and osteogenesis [Robling 2009, Kohrt et al. 2009, Iwaniec and Turner 2016].
Due to the proximity and the involvement of bone and skeletal muscles during
locomotion, the concept of a “muscle-bone unit” was developed, though the underlying
mechanisms are still poorly understood and most of the cell and tissue biochemical interactions
remain mostly unknown [Abreu et al. 2012]. Despite these unknown crosstalk mechanisms,
11

studies have shown the connection of these two tissues. During foetal development, it has been
shown that the shape of long bones and joints is dependent on muscle contraction; the lack or
absence of mechanical loads results in abnormal bone morphology and mechanically inferior
bones with reduced load-bearing capacity [Bren-Mattison et al. 2011, Sharir et al. 2011]. In
addition, during a bone healing event, the presence of muscle has been shown to be beneficial
as it is highly vascular, allowing for increase blood supply access to bone [Davis et al. 2015].
Studies are also beginning to show that muscle may serve as a “secondary periosteum,”
containing (osteo)progenitors that can travel to the site of injury and promote bone growth in
the event that bone’s innate periosteum is damaged [Liu et al. 2010]. These observations, in
addition to those seen during puberty, where bone mass is growing in proportion to increased
muscle strength [Schoenau 2005], has led many to support the muscle-bone unit concept and
linkage of the two tissues.

1.7 Bone Disuse
Mechanical loading within the normal physiological range can produce anabolic and
catabolic effects in order to maintain the bone matrix. Under-loading (unloading), which occurs
during low activity level and sedentariness, can produce catabolic effects and lead to tissue
degradation. This allows bone to adjust the amount of bone tissue according to structural
demand. Skeletal unloading (disuse), such as with spaceflight, long-term bed rest, and
neuromuscular damage, has been shown to negatively disrupt the bone mass balance. Bone loss
is also heavily associated with ageing as oestrogen levels decrease, causing an accelerated loss
of bone that may manifest into osteoporosis. Though bone loss is mostly known to occur within
post-menopausal women, the effects can also be seen within men during ageing [Komori 2015].
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1.8 Muscle Disuse
Ageing is defined as the loss of tissue function over time [Maurel et al. 2017] and is one
of the main factors resulting in the weakening of both muscle and bone strength. The term
sarcopenia was first used to describe the loss of lean body mass with age [Rosenberg 1989] and
then expanded to include lower muscle mass (atrophy) and muscle weakness or impairment
[Cruz-Jentoft et al. 2010]. Upsetting the balance between protein synthesis and degradation
can be caused by improper nutrition, hormonal imbalances, physical activity and exercise,
injury, diseases, etc. [Frontera and Ochala 2015]. A reduction in muscle mass has also been
shown to impair the ability to respond to external stressors and chronic illness [Frontera and
Ochala 2015].

1.9 Disuse Models
Currently, rodents are commonly used as models to study the effects of and induce
disuse in bone and muscle. To study the effects of immobilization, sciatic neurectomy,
tenotomy, bandages, and plaster casts are common models used. To mimic the removal of
weight bearing loading more closely, like in a microgravity environment, hindlimb (tail)
suspension is used. These models are useful for defining the calcium homeostasis over time,
which is not possible during a single spaceflight experiment [Chappard et al. 2001]. In tail
suspension models, rodents are suspended with their head tilted approximately 30° using a
harness to hold the hind limbs up [Morey-Holton and Globus 2002]. The rodent places its full
body weight on its forelimbs, which allows full range of motion to access food and water. These
experiments result in bone formation being inhibited, while bone resorption is enhanced or
unchanged in trabecular bone [Komori 2015]. The reduced mechanical loading that is caused
by the lower stresses and strains in the bone tissue results in less bone mass being necessary to
13

maintain the structural integrity of the skeleton [Chappard et al. 2001]. For these experiments,
the forelimbs are the internal control bones to distinguish between local and systemic effects
of hindlimb unloading because they undergo normal loading. This hindlimb suspension model
removes exogenous gravitational forces effects, like during spaceflight; however, one limitation
of the model is that the hindlimb muscles are still able to contract.
In newer methods that have been developed to investigate muscle/bone disuse, Botox
is used in intramuscular injections in order to induce a transient paralysis of the injected limb
muscles by preventing the release of acetylcholine at the neuromuscular junction, which then
ultimately blocks muscle contraction [Warner et al. 2006, Chappard et al. 2001]. Over time,
this blockade wears away, allowing for the muscle to return to its previous contraction ability
[Martyn et al. 2009, Broide et al. 2013]. The procedure results in muscle degradation and
reduced bone mass in rodents. In addition, the bone loss that occurs has been shown to be
greater than the resulting bone loss from hindlimb suspension [Warner et al. 2006]. The work
presented in this thesis uses a hindlimb Botox injection in rats to produce muscle paralysis.

1.10 Real-time Polymerase Chain Reaction (qPCR)
Real-time polymerase chain reaction (qPCR) is a technique used to reliably detect and
quantify the products of the polymerase chain reaction (PCR) process. qPCR is the more
advanced technique compared to traditional PCR, which is a technique that was developed to
amplify the amount of DNA for analysis [Mullis 1990], by combining it with fluorescence
chemistry and making the technique more widely available [Peirson and Butler 2007]. By
increasing the DNA, more is available to be used in subsequent analysis, which is useful for
comparing different samples. You can use primers, or small pieces of DNA that complement a
gene of interest, in order to detect the expression of various genes, amplify rare DNA, identify
criminals from evidence in a crime scene, and more [Garibyan and Avashia 2013, Peirson and
14

Butler 2007]. Traditionally, PCR is followed through electrophoresis analysis to determine the
amount of cDNA in the sample [Garibyan and Avashia 2013]. With qPCR, DNA is monitored using
a detector within a thermocycler, where gene amplification is detected through fluorescence
from fluorescent dyes. An intercalating dye, such as SYBR green, can be used as a fluorescence
marker that fluoresces more based on the number of gene copies amplified, as it primarily
binds to double-stranded DNA [Ponchel et al. 2003]. In addition, a dissociation (melt) curve is
used to ensure the correct amplicon is detected during the reaction; it is used to analyse the
homogeneity of the PCR products by making sure there is no genomic DNA contamination and
that the primers did not bind to themselves, forming primer dimers [Lorenz 2012]. Avoiding
these issues, successful qPCRs result in the expression of genes of interest, where a quantitative
comparison can be made among experimental groups. In this project, qPCR is used to assess
relative gene expression of several genes of interest using quadriceps muscles.

1.11 Muscle-related Genes of Interest
In this project, several genes of interest were isolated based on their involvement with
muscle and bone: Tgf-β1, Gdf-8/Mstn, Fgf-2, and Igf-1.

Transforming Growth Factor Beta 1 (Tgf-β1)
The Tgf-β superfamily is involved in cell growth regulation, ECM remodelling, wound
healing, carcinogenesis, angiogenesis, and inflammation amongst other functions [Kim and Lee
2017]. In muscle, it is known to delay muscle differentiation through the Smad-3 signalling
pathway, where muscle generation is delayed because positive muscle cell differentiation
regulators remain inactive. This causes satellite muscle cells to remain undifferentiated and
inactive, where Tgf-β1 has been shown to induce muscle weakness and atrophy, as well as
reduce muscle fibre size and maximal isometric strength [Narola et al. 2013, Mendias et al.
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2012]. In bone, all three isoforms of Tgf-β are expressed, where Tgf-β1 is the most abundantly
produced isoform at the protein level [Janssens et al. 2005]. Tgf-β1 promotes ECM matrix
production, ECM matrix protein secretion, osteoblast proliferation and differentiation, and
attenuates osteoblasts’ secretion of RANKL, limiting osteoclast formation [Chen et al. 2012].

Myostatin/Growth Differentiation Factor-8 (Mstn/Gdf-8)
Myostatin is largely expressed in skeletal muscle (essentially exclusively so in adults)
and is known to be a negative regulator of muscle growth [Elkasrawy and Hamrick 2010]. Mutant
vertebrates that lack the gene affected grow larger muscles with more muscle fibres than their
wild-type counter parts; homozygous animals grow muscles that are twice the weight of wild
types, and heterozygous mutants have an intermediate increase between the homozygous wild
types and animals homozygous for Mstn gene deletions [Szabó et al. 1998, McPherron and Lee
1997, Mosher et al. 2007]. As bone strength is typically linked to higher muscle strength [Russo
2009], this gene was investigated in the present study as it may be a possible link between
muscle and bone. The Tgf-β superfamily, which Mstn belongs to, contains several members of
which have been implicated in bone turnover [Dankbar et al. 2015]. Myostatin has been linked
to bone, where its expression has been shown to regulate osteoclast differentiation and its
deficiency reduces the severity of rheumatoid arthritis in human tumour necrosis factor (TNF)α transgenic (hTNFtg) mice [Dankbar et al. 2015]. In muscle, myostatin plays a role in
development, but also in adult life, where it is known to be a negative regulator of muscle mass
[Tobin and Celeste 2005]; loss of myostatin function in dogs, cows, humans, and mice has been
shown to result in increased muscle mass [Elkasrawy and Hamrick 2010, Buehring and Binkley
2013].
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Fibroblast Growth Factor 2 (Fgf-2)
Fgf-2, also called basic fibroblast growth factor, is known for being an osteogenic factor.
In bone, Fgf-2 is expressed by osteoblasts [Montero et al. 2000]; it stimulates osteoblast
differentiation and bone formation by modulating the Wnt/β-catenin pathway [Adhikary et al.
2019], but it has also been shown to be expressed in the brain, peripheral nerves, skeletal
muscle, smooth muscle, heart, chondrocytes, and more [Coffin et al. 2018]. In skeletal muscle,
it is localised at the bone and muscle interface, is released by eccentric lengthening
contractions and muscle injuries, and has been shown to promote skeletal muscle proliferation
and differentiation through MAP kinases and inversely regulates the expression of myostatin in
the cells [Hamrick 2012, Adhikary et al. 2019].

Insulin-like Growth Factor (Igf-1)
Igf-1 is a hormone expressed in almost all tissues of the body (autocrine/paracrine
system) and as an endocrine hormone in serum [Goldspink 2005, Yakar et al. 2010]; it promotes
osteoblast and osteoclast proliferation and differentiation, and manipulates RANKL/OPG
binding to regulate bone formation and resorption [Yakar et al. 2009]. In muscle, Igf-1 is known
to be anabolic, where increases in tissue mRNA are seen with muscle contraction and serum
after resistance exercise [Hamrick 2012]; however, it is less understood during muscle atrophy.

1.12 Previous Botox-Injection Results and Project Research Hypothesis
To extricate the contributions of muscle and bone to the muscle-bone unit, a muscle
paralysis disuse model is necessary in order to isolate each system’s contribution to the unit.
We will utilise a rat model to study the effects of Botulinum toxin A (Botox)-induced muscle
paralysis on muscle and bone. In a previous study by our lab, a Botox study was performed that
analysed bone changes over 4 weeks due to muscle hindlimb paralysis [Gatti et al. 2019]. In
17

that study, Botox injection produced a decrease in the osteocyte lacunar density in the proximal
tibial metaphysis in the injected limb and a decrease in the cortical thickness, area, and area
fraction when compared to the saline-injected control group. A lower cancellous bone volume
fraction was seen when comparing the Botox-injected limb to the contralateral.
The loss of muscle function has been shown in our previous study as well as other studies
to precede that of bone during physical inactivity caused by mechanical unloading [Lloyd et al.
2014]. This temporal lag raises questions: what morphological changes in muscle precede that
of bone? What parameters (signalling, genetic factors, control systems, etc.) do these two
systems share, if any, and what are the overlaps/divergences? We hypothesise that within one
week of muscle paralysis, we should expect to see increases in osteocytic apoptosis as well as
other osteocyte markers within bone, and a genetic profile promoting muscle atrophy. To
address this hypothesis, this project aims to utilise immunohistochemical and qPCR analyses to
determine changes in muscle and bone over the course of one week after Botox injection. In
addition, the effects of Botox injection on gait will be monitored during the experiment to
track paralysis over time by using both gait and digit abduction assessments.…

2. Methods
2.1 Animal Model
Muscle paralysis was induced using injections of botulinum toxin A (Botox, Allergan Inc.)
in the hindlimb muscles of skeletally mature rats to induce a transient paralysis of the injected
muscles, as previously done in our lab [Gatti et al. 2019]. As mentioned previously, Botox
prevents the release of acetylcholine at the neuromuscular junction, which then results in a
transient muscle paralysis. This model was chosen to explore the role of muscle function in the
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maintenance of bone mass without altering gravitational forces. All procedures were approved
by the Institutional Animal Care and Use Committee (IACUC) of The City College of New York.

2.2 Experimental Design
Twenty-four 20-week-old female Sprague-Dawley rats (Taconic) were randomized into
two groups such that the mean weight was approximately the same in both groups. The rats in
the experimental group (BTX, n=12) were injected with four units of Botox dissolved in 0.2 mL
sterile phosphate buffered saline (PBS) in the right hindlimb while under isoflurane anaesthesia.
The upper quadriceps, lower quadriceps, gastrocnemius, and biceps femoris all received one
unit of Botox with a volume of 0.5 mL for each injection. The rats in the control group (CTRL,
n=12) received saline injections of the same volume in the same locations, in place of Botox.
After one week of muscle paralysis, carbon dioxide euthanasia was used to sacrifice both
groups, according to IACUC guidelines. The one-week time point was chosen to determine
mechanism(s) that may have caused the changes in bone that we saw in our previous 4-week
study.

2.3 Assessments of Gait and Digital Abduction Score
To track the immobilization of the rats, gait assessments were performed on day 0 to
insure normal gait before the experiment, and again on Days 1 and 5 post-injection. The
protocol from Warner et al. [2006] was used, where each gait assessment exercise was scored
0-2, with 0 being no mobility and 2 being normal (Table 1), while the observer was blinded to
the treatment group. The five observations on the right (injected) limb can result in a maximum
score of 10. In addition to the gait assessment, the digital abduction score (DAS) was also
assessed for each rat, following the protocol from Broide et al. [2013]. Briefly, the DAS response
was recorded on a five-point scale, with 0 being no effect and 4 being the maximum reduction
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in digit abduction (Figure 1). The DAS response was obtained by simulating an air drop onto a
flat surface; rats were held by their torso and picked up, gently dropped, and then when the
rat braced for “impact,” they were flipped into a reclining position (held with their feet facing
upward) and their toe spread was scored. Gait assessments were also video-recorded for each
animal.

Table 1: Gait assessment observations (taken Days 1 and 5). Adapted from Warner et al. 2006.
Possible Score

Observations

0,1,2

Use of the injected limb during level walking

0,1,2

Use of the injected limb during climbing

0,1,2

Use of the injected limb during two-legged standing stance

0,1,2

Use of the injected limb during abduction during tail suspension

0,1,2

Use of the injected limb during right-toe extension while sitting
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Figure 1: Digital abduction score (DAS) response patterns
of

rats

following

intramuscular

Botox

injections.

Depending on the muscle injected (gastrocnemius (G) or
tibialis anterior (TA)), rats show two possible patterns of
digit abduction. For this study, we focused on the
gastrocnemius response. Numbers correspond to the
scores given for the DAS assessment; 0 = no effect; 4 =
maximum reduction in digit abduction Republished with
permission of Elsevier from Broide et al. 2013.

2.4 Assessment of Body Mass and Muscle Mass
Body mass was recorded during the experiment on days 0, 1, 5, and 7 post-injection.
Immediately after sacrifice on day 7, left and right gastrocnemius/soleus and quadriceps
muscles were harvested and weighed for all animals before snap-freezing and storing at -80°C
for subsequent analyses.

2.5 Osteocyte and Vascular Pore Immunohistochemical Analyses
After sacrifice, tibiae were extracted from both hindlimbs for both groups and bones
were fixed in 10% phosphate buffered formalin for 48 hours. For the immunohistochemical
analyses, the tibiae were cut 3 mm below the proximal growth plate. This region was selected
because in our previous study, cortical bone micro-CT analysis showed a volumetric loss, lower
maximum principal moment of inertia and polar moment of inertia, with increased vascular
porosity in the tibial metaphysis that was consistent with endocortical resorption [Gatti et al.
2019]. The samples were then dehydrated in a series of decreasing ethanol dilutions before
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paraffin embedding. 4.5-µm thick cross-sections were cut from the paraffin-embedded bone,
where sections were obtained moving proximally from the distal cut.
After sectioning, samples were then incubated with polyclonal goat anti-rabbit
sclerostin (R&D systems), polyclonal rabbit anti-cathepsin K (ab19027, Abcam), and polyclonal
rabbit anti-active caspase-3 (ab2302, Abcam) primary antibodies to assess sclerostin (Scl)
secretion, perilacunar remodelling, and apoptosis in osteocytes, respectively. Chromogen was
used to visualise the antibody staining, and toluidine blue was used as a counterstain. Samples
were then mounted to glass slides using Eukitt mounting media. Positive and negative controls
were tested with these antibodies to verify staining. Assessments were made by counting
stained and unstained osteocytes using the OsteoMeasure software (Osteometrics, Inc.) under
20X magnification within regions of interest for the medial, lateral, posterior, and anterior
cortical bone, within 160 µm x 160 µm boxes in the endosteal, intracortical, and periosteal
surfaces (3 boxes per section, Figure 2). 12 boxes were analysed per bone. Percent osteocytes
stained as well as percent vascular pores stained at the surface were also measured in these
regions. The observer was blinded to the treatments for all counts.

Figure 2: Immunochemistry regions for analysis. The proximal tibia cortical bone was analysed
within each of the cortex layers (Right: endosteal, intracortical, periosteal) in the anterior,
posterior, medial, and lateral regions (Left: A, P, M, and L, respectively) using 160 µm x160 µm
boxes to count stained and unstained osteocytes.
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2.6 Mast Cell Analysis
After noticing their presence on the immunohistochemistry slides, we decided to
quantify mast cells to see if there were any observable differences between groups.
Assessments were made using the OsteoMeasure software (Osteometrics, Inc.) under 20X
magnification to count mast cells within the bone marrow. Cells were counted in the anterior
region of the trabecular bone.

2.7 RNA Isolation and Real Time Polymerase Chain Reaction (RT-qPCR)
Analysis
The genes Myostatin/Growth Differentiation Factor-8, Fibroblast Growth Factor 2, and
Transforming Growth Factor Beta 1, Insulin-like Growth Factor 1 (Mstn/Ggf-8, Fgf-2, Tgf-β1,
Igf-1, respectively) (see Table 2 for primer sequences) were chosen to determine the genetic
expression in muscle. All four of these genes were chosen due to their musculoskeletal
involvement, where they have been shown to be found in both skeletal muscle and bone.
Quadriceps muscles were chosen for analysis as this muscle showed the largest mass
difference in our previous 4-week Botox study [Gatti et al. 2019]. Frozen quadriceps muscle
samples were ground into a fine powder using liquid nitrogen and a mortar and pestle. The RNA
was then isolated using QIAshredder and RNeasy Fibrous Tissue Mini Kit (QIAGEN), according to
the manufacturer’s instructions. To avoid genomic DNA contamination, the samples were
subjected to additional digestion with DNase using RNase-Free DNase Set (QIAGEN) included in
this kit. The RNA concentration was determined by measuring the absorbance at 230 nm,
260nm, and 280 nm, using a Micro-volume plate (Agilent). The purity of the RNA was estimated
by calculating the A260/A280 ratio. The samples were then stored at -80°C until ready for use.
These samples were then used to obtain cDNA via reverse transcription using the QuantiTect
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Reverse Transcription Kit (QIAGEN) and the manufacturer’s instructions. For the qPCR,
glyceraldehyde 3-phosphate dehydrogenase (GAPDH) was used as a reference gene to serve as
an internal standard to ensure that equal RNA concentrations were used in each sample during
the analysis. Rat-specific Mstn (Gdf-8), Fgf-2, Tgf-β1, and Igf-1 primers were used (Table 2).
Crystallized primers were resuspended with TE buffer (10mM Tris pH 8.0, 1 mM EDTA) using a
volume ten times the number of nanomoles of RNA present in the tube to make a 100 µM
concentration stock, which was then stored at -20°C. To make a working primer solution for
subsequent analysis for each gene, 20 µL from these stocks (forward and reverse) were diluted
with 160 µL of RNase free water to get a 10 pM concentration. This working solution was also
stored at -20°C until ready for analysis. Primers were quality checked by running a polymerase
chain reaction and running the samples through 1% agarose gel plus added ethidium bromide
and DNA ladder buffer dye to ensure single bands were present and specific amplification was
occurring.

Table 2: Candidate gene names and associated PCR primer pair sequences used for qPCR.
Gene

Mstn

Accession

Forward Sequence (5’-

number

3’)

NM_019151

Reverse Sequence (5’-3’)

CGCCTCCACTCCGGGAACTGA

TGGGCTTTCCATCCGCTTGCATT

Reference

Grönholdt-Klein et
al. 2019

Fgf-2

NM_019305.2

AAGCGGCTCTACTGCAAG

TCCGTGACCGGTAAGTGTTG

Li et al. 2000
Agca et al. 2013

Tgf-β1

NM_021578.2

CCTGGAAAGGGCTCAACAC
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CTGCCGTACACAGCAGTTCT

Chen et al. 2014

Igf-1

NM_178866

GTAGGTCTTGTTTCCTGCAC

CACATCTCTTCTACCTGGC

Dubé et al. 2006

GAPDH

NM_017008.4

GAGGACCAGGTTGTCTCCTG

GATGTAGGCCATGAGGGCCAC

Kennedy et al. 2012

Using the Power SYBR™ Green PCR Master Mix (Applied Biosystems), qPCR was run using
the manufacturer’s protocol, using a final volume of 25 µL, which includes 1 µL of reversetranscribed cDNA, 12.5 µL of SYBR Green, 1 µL of the previously mentioned forward and reverse
primer solution, and the remaining amount being RNAse free water. Thermocycling conditions
were as follows: an initial denaturation at 95°C for 10 minutes, followed by 45 cycles of 95°C
for 20 s, 60°C annealing for 30 s and 72°C extension for 30 s and holding at 4°C. Cycle threshold
(Ct) values obtained from the thermocycler were used for analysing genetic expression and
subsequently analysed for differences in expression levels. Outliers (samples with CT replicates
with standard deviation of more than 2) were then removed from all the groups. To analyse the
data, for each gene of interest, the two replicate CT values were averaged, and the average
CT value for the reference gene (GAPDH) was calculated as well. To get the normalized
expression level of the gene of interest, for each sample, the left leg of the CTRL group was
chosen to be a representative “calibrator” for the entire experiment as it would not have any
potential effects from Botox or from the injection procedure itself. The average CT was then
calculated for GAPDH and all four groups for each gene of interest. The relative expression
level for each gene of interest was then calculated using the equation below, where the
expression level for the calibrator equates to one. The same was done with the reference gene.
𝑅𝑒𝑙𝑎𝑡𝑖𝑣𝑒 𝐸𝑥𝑝𝑟𝑒𝑠𝑠𝑖𝑜𝑛 𝐿𝑒𝑣𝑒𝑙 = 23(∆6789:;<= >=?= 3∆67@9<ABC9DEC 9F> )
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2.8 Statistical Analysis
Data were confirmed for normality before using two-way repeated-measures ANOVA
with Sidak multiple comparison tests to compare gait ability scores and digit abduction scores
(DAS) for the BTX and CTRL groups. The time points used for calculations were for
measurements taken on day 0 and days 1, 5, and 7 post-injection. The same statistical tests
were used for body mass and muscle mass as well. Immunohistochemical measurements were
analysed using two-way repeated-measures ANOVA with Sidak multiple comparison tests to
investigate whether there were locational differences by comparing left versus right and Botox
versus saline-injected. Statistical analyses were performed using Prism 8 (GraphPad, Inc.) with
a significance level of 0.05.

3. Results
3.1 Assessments of Gait and Digital Abduction Score
During the 1-week experiment, the gait and digital function of the injected hindlimb
was significantly altered in the Botox-injected group compared to saline-injection controls. The
gait assessment showed a reduced gait score of BTX rats starting from day one and remaining
at day 5 (Figure 3). The median digital abduction score (DAS) for the BTX group increased from
zero (Day 0 and Day 1 assessments) to 2 (day 5 assessment), whereas CTRL remained at zero.
BTX rats did not drag the injected limb behind while walking; the injected limb was paralyzed
in a contracted position (Figure 4), which was maintained during gait. Motion of the Botoxinjected limb appeared to be initiated from the hip, but the contraction could not be
completed, so the leg was lugged forward and the foot was used as a crutch (rotation forward
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like on a rocking chair from the ankle to the stationary toes) while the animal moved the
contralateral rear leg, resulting in an unlaboured hopping motion.

Figure 3: (Left) Box plot for the Gait Score (n=12 per group), which was reduced in BTX
compared to CTRL at Day 1 and Day 5 post-injection (*p<0.05 vs. CTRL); (Right) Digit Abduction
Score (DAS) showing reduction of digit abduction due to paralysis of the gastrocnemius (calf)
muscle on Day 5 (*p<0.05 vs. BTX right; 0 indicates normal digit abduction).

Figure 4: Example of a BTX rat injected hindlimb. For all rats in the group, the leg was kept in
a contracted position with toes curled, showing the effect of Botox paralysis on the limb on Day
5 post-injection.
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3.2 Assessment of Body Mass and Muscle Mass
While there were no observed differences in body mass at day 7 (CTRL: 316 ± 12g; BTX:
309 ± 32g) (Figure 5), after one week of Botox paralysis the muscle mass for the quadriceps
had decreased by 26% compared to the injected CTRL limb (Figure 6). Calf muscles showed a
similar 23% reduction in muscle mass when comparing injected limbs of BTX to CTRL (Figure
6).

Figure 5: Body mass ± SD for BTX and CTRL groups throughout the one-week study.

Figure 6: Botox-injected rats showed reduced quadriceps and calf muscle mass in the injected
limb compared to the contralateral limb (ap<0.05) and compared to CTRL (bp<0.05), and the
calf muscles also showed a reduction in the left, non-injected BTX leg when compared to CTRL
(bp<0.05).
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3.3 Osteocyte and Vascular Pore Immunohistochemical Analyses
Quantitative analysis demonstrated no differences in the percentage of cathepsin K
expressing osteocytes, osteocyte synthesis of sclerostin, and caspase-3 stained osteocytes
between the CTRL and BTX groups overall; however, some regions within the bone
demonstrated differences for perilacunar remodelling (cathepsin K). For cathepsin K,
differences between the BTX-injected and non-injected legs occurred in the medial and
intracortical regions of the bone when comparing percent stained osteocytes (Figure 7), where
percent difference between the right legs of CTRL and BTX were 25.9% and 12.9%, respectively.
There were no significant differences for any of the regions of bone for sclerostin (Figure 8) or
caspase-3 (Figure 9).
Quantitative analysis of staining of the surface of cortical vascular pores demonstrated
a significant difference in Scl-stained vascular pores in the endosteal region. The BTX-injected
right limb was less than the BTX left limb (-35.9%) and the CTRL saline-injection right limb was
greater than the CTRL left limb (+24.0%) (Figure 10). Otherwise, no differences in vascular
pore staining were found.
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Figure 7: Percentage of cathepsin K stained osteocytes in the tibia cortex and whole bone
analyses (mean±SD with individual data points shown) of the left and right (injected) legs of
the saline-injected (CTRL) and Botox-injected (BTX) groups. (* represents a p-value < 0.05 using
two-way repeated-measures ANOVA with Sidak's post-hoc test)
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Figure 8: Percentage of Scl stained osteocytes in cortical bone (mean±SD with individual data
points shown) of the left and right (injected) legs of the saline-injected (CTRL) and Botoxinjected (BTX) groups. (* represents a p-value < 0.05 using two-way repeated-measures ANOVA
with Sidak's post-hoc test)
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Figure 9: Percentage of caspase-3 stained osteocytes in cortical bone (mean±SD with individual
data points shown) of the left and right (injected) legs of the saline-injected (CTRL) and Botoxinjected (BTX) groups. (* represents a p-value < 0.05 using two-way repeated-measures ANOVA
with Sidak's post-hoc test)
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Figure 10: Percentage of Scl stained vascular pores in the entire cortical bone (mean±SD with
individual data points shown) of the left and right (injected) legs of the saline-injected (CTRL)
and Botox-injected (BTX) groups. (* represents a p-value < 0.05 using two-way repeatedmeasures ANOVA with Sidak's post-hoc test)

3.4 Mast Cell Analysis
Counts of mast cells within the bone marrow using the immunohistochemical slides
stained for cathepsin K, Scl, and caspase-3 showed no differences between CTRL and BTX
(Figure 11).

Figure 11: Number of mast cells counted in the bone marrow for all three immunohistochemistry
stains (number ± SD). R = right (injected); L = left (contralateral). BTX-L was not analysed.
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3.5 Real-time Quantitative Polymerase Chain Reaction Muscle Analysis
Relative gene expression was calculated for all four genes of interest using the relative
expression level technique described in section 2.7. Fgf-2, Tgf-β1, and Igf-1 showed no changes
after one week of Botox paralysis, and the analyses resulted in large standard deviations. Mstn
showed higher expression in BTX left compared to BTX right and both CTRL limbs (Figure 12).
Additionally, Igf-1 CTRL right could not be compared as not enough data points were available
after outlier removal.

Figure 12: Analysis of relative gene expression level data using real-time quantitative PCR for
genes of interest standardised against CTRL left (mean ± SD). For Igf-1, CTRL Right did not have
enough data points for analysis, so it was not included.
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4. Discussion
Previous work has shown that Botox-induced paralysis of the hindlimb muscles in
skeletally mature rats causes decreases in muscle mass, gait function, osteocyte lacunar
density, and cortical thickness, and an increase in the intracortical vascular porosity after four
weeks of disuse. The goal of the present study was to investigate the development of these
muscle paralysis-induced bone changes by assessing muscle and osteocyte function at an earlier
time point after reduction of muscle contractions. Skeletally mature rats were injected with
Botox and the duration of the experiment was decreased from four weeks to one week. The
results demonstrate that the Botox model is effective at inducing paralysis, with a significant
reduction in hindlimb muscle mass, gait ability, and digital abduction score one week postinjection. The only changes in osteocyte activity were a lower percentage of cathepsin K
stained osteocytes in the intracortical and medial regions of bone of BTX-injected limbs.
Additionally, the quadriceps of BTX left showed an increase in myostatin expression levels
compared to BTX right and both CTRL legs.
Gait scores were significantly lower in the BTX group compared to CTRL, following the
same trend seen during our four-week study, and similarly to other studies [Warner et al. 2006,
Gatti et al. 2019]. An additional muscle function test performed was the Digit Abduction Score
as described in Broide et al. [2013]. As with their study, BTX rats demonstrated decreased
movement of their toes, which corresponded to calf paralysis. This decrease in digit abduction
is not unique to rats, as the same test can also be observed in mice injected with Botox [Broide
et. 2013, Aoki 2001]. While no differences in body masses were observed between groups, there
was a significant decrease in the BTX right (injected) calf and quadriceps muscles when
compared to that of CTRL, a result that was also seen in Worton et al. [2018].
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Rats in the BTX group may have had partial weight bearing despite muscle paralysis due
to the use of the Botox-injected limb to balance while moving. This may affect the bone’s
response to the paralysis because it is likely that there is still load-dependent fluid flow within
the injected-limb. As bone is a dynamic tissue that responds to mechanical loading, this altered
gait leads us to question whether this model has the minimum effective loading required to
prevent remodelling—at least for one week. In a study on ulna in skeletally mature turkeys, it
was found that removal of loadbearing resulted in substantial remodelling of endosteal,
intracortical, and periosteal bone; however, as little as four consecutive cycles a day at altered
strain distribution under physiological strain magnitudes or exposure to 36 0.5Hz cycles per day
was sufficient in attenuating the effects of disuse-induced osteoporosis [Rubin and Lanyon
1984]. In fact, in another study, 100 cycles of strains as low as 1000 microstrain were able to
retain the original bone area in an avian disuse model [Rubin and Lanyon 1987]. In hindlimb
unloading studies of mice, it was found that although reduced gravitational weight bearing did
not protect hindlimb bone and muscle atrophy completely, it did reduce the effects of
unloading on the cancellous bone microarchitecture and biomechanics found in complete
unloading in skeletally mature BALB/cByJ mice [Swift et al. 2013]. Thus, strain gauging would
be helpful to determine the magnitude of loading on the tibia in this model in future studies.
Immunohistochemical analyses assessing osteocyte activity showed only localized
differences in cathepsin K. CatK had a lower percentage of osteocyte staining in the medial
and intracortical regions of the BTX-injected limbs compared to the contralateral control. As a
marker for perilacunar modelling, increased CatK staining measured in osteocytes has also been
shown to occur in the intracortical regions of bone after fatigue loading in rat ulnae [Bentolila
et al. 1998], and the in distal femur of hindlimb unloaded rats [Metzger et al. 2017]. In the
proximal tibia, the load distribution from the knee is higher in the medial surface than in the
lateral in humans [Chong et al. 2011], thus remodelling of this area can have severe effects on
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gait and fracture risk. CatK positive osteocytes were expected to increase after Botox injection,
especially since in our 4-week Botox study there were decreases in intracortical properties in
the tibia due to remodelling (cortical thickness, cortical area, cortical area fraction, and
maximum principal and polar moments of inertia) [Gatti et al. 2019].
Sclerostin, which inhibits the Wnt signalling pathway and thus bone formation, showed
no differences in BTX compared to CTRL. Although our % stained osteocyte values are similar
to those found in the literature, other studies observed an increase in positive Scl staining. In
hindlimb unloading studies, skeletally mature rats and young mice saw significant increases of
sclerostin-positive stained osteocytes [Robling et al. 2008, Macias et al. 2012, Metzger et al.
2017]. OVX and sciatic neurectomy-induced disuse studies also saw increases in positively
stained osteocytes when looking at sclerostin [Moustafa et al. 2012, Sun et al. 2015].
The presence of caspase-3 was measured to assess osteocyte apoptosis, and no
differences were found between BTX and CTRL. Murine hindlimb unloading studies and a study
modelling orthodontal tooth movement showed increases in osteocyte apoptosis [Basso and
Heersche 2006, Cabahug-Zuckerman et al. 2016, Kassem et al. 2017], which is expected in cases
of disuse. The results for caspase-3, CatK, and sclerostin all had high standard deviations due
to variability in staining. This may have hidden potential differences in % osteocyte staining
that would have matched more closely to that in the literature.
Mast

cells

were

observed

in

the

bone

marrow

while

performing

the

immunohistochemical analyses. These cells are most notably known for their role in the body’s
immune response to allergies but may also have osteoprotective and catabolic roles in bone
homeostasis [Ragipoglu et al. 2020]. However, mast cell analysis showed no differences
between any of the groups; the number of mast cells was similar in both BTX and CTRL groups.
To assess potential crosstalk between muscle and bone, qPCR of quadriceps muscles was
carried out on genes known for having musculoskeletal involvement, including Tgf- β1, which
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showed no statistical differences in BTX versus CTRL. In another Botox study by Pingel et al.
[2017], an increased relative gene expression of Tgf-β1 was seen 21 days after Botox injection
in the gastrocnemius of adult male Sprague-Dawley rats. Whereas in a hindlimb suspension
study, there was no difference in the expression of Tgf-β1 after one and two weeks of
suspension when compared to day zero, but after reloading the limbs, the investigators saw a
significant upregulation of the cytokine in the soleus muscle of young adult female SpragueDawley rats when compared to control legs [Heinemeier et al. 2009]. Thus, Tgf-β1 may act
differently in the two disuse techniques, where it may respond to weight bearing rather than
unloading.
The expression of myostatin, another member of the Tgf-β family, was also analysed in
the quadriceps muscle. Catabolic disuse conditions, such as long-term bedrest and
microgravity, show increased local and circulating levels of myostatin [Hamrick 2011, Hamrick
2012, Reardon et al. 2001], which led us to believe we would see the same in our study. Our
results showed a higher relative myostatin expression in the left, uninjected BTX limb compared
to BTX-injected and both CTRL limbs; there was no increase in the Mstn level in the BTXinjected limb. A possible explanation is that the one-week time point may have been too
early/late to detect Mstn expression changes. For example, Baumann et al. [2003] saw a
significant decrease in myostatin 24 hours and 14 days after denervation in calf muscles in
young growing male Sprague-Dawley rats. Perhaps in the BTX left leg, although circulating Mstn
values were not analysed in this study, there may have been a higher level of circulating Mstn
that was present in the muscle to regulate the dimorphism between the two hindlimbs.
The qPCR analysis of quadriceps muscle also included the measured expression levels of
Fgf-2, and no differences were found between BTX and CTRL. In a 15-day spaceflight study,
C57BL/6J femoral marrow stromal cells expressed a negative fold change of Fgf-2 [Blaber et
al. 2014], which is what we expected for our BTX groups. Additionally, lower Fgf-2 expression
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would help explain the increase in myostatin expression. Adhikary et al. [2019] also
demonstrated in their in vitro study that C2C12 myoblast cells treated with Fgf-2 then exposed
to dexamethasone to mimic glucocorticoid-induced osteoporosis expressed lower levels of
myostatin.
The last gene of interest in the qPCR analysis of quadriceps muscles was Igf-1, which
showed no changes in relative expression one week after BTX injection. In other studies, young
adult rats tail suspended for approximately one week did not show differences in the mRNA
expression of Igf-1 in gastrocnemius muscles [Adams et al. 2007, Heinemeier et al. 2009]. In a
hindlimb suspension study in mature male mice, the expression of Igf-1 was significantly lower
three days and 14 days after initial hindlimb suspension in the soleus muscle [Hanson et al.
2013]. In a study on chronic disuse atrophy in humans, researchers found that Igf-1 expression
was upregulated in the ipsilateral vastus lateralis muscle five and 30 days after total hip
arthroplasty, which the authors credited may be because it is possibly involved in the fibre type
switching seen in muscle disuse studies [Reardon et al. 2001].
In future studies, the current study design can be improved in several ways. Firstly, rats
in the BTX group, despite apparent paralysis, were observed to have partial weight bearing by
hopping on the injected-leg like a crutch. By observing the gait of the rats with a force plate
beneath them, we could analyse whether partial weight bearing effects differences in the bone
and muscle. Secondly, despite there being few significant differences in osteocyte activity
overall, it would be interesting to analyse osteocyte expression in the trabecular bone.
Phalloidin staining to quantify differences in osteocytic connections can also be performed to
see if disuse affects this network, as these dendritic connections are used for osteocytes to
communicate with one another. Thirdly, performing immunohistochemical analyses on baseline
animals would be useful to determine if there are any differences in osteocyte apoptosis or
bone remodelling at day 0 versus day 7. Fourthly, several improvements could be made to the
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qPCR analyses in this study: genetic expression from baseline animals should be quantified to
get baseline values; calf muscles could also be analysed, as these tissues were excised but not
analysed despite being a predominately fast oxidative extensor muscle [Atherton et al. 2016].
In addition, CTRL right qPCR results had large standard deviations and were unusable in the Igf1 analyses. As all of the CTRL samples were stored together and processed together, there may
have been mishandling or contamination of the samples. Lastly, more biomarkers could be
included in the qPCR muscle analysis that are relevant to disuse atrophy, such as additional
muscle biomarkers: RING finger 1 (MuRF1), muscle atrophy F-box (MAFbx)/atrogin-1, forkhead
box O1 (Foxo1), forkhead box O3a (Foxo3a), tripeptidyl peptidase II (TPPII), Nuclear factorkappaB (Nfkb1), or NF-κB co-transactivator (Bcl-3) [Atherton et al. 2016, de Boer et al. 2007,
Wu et al. 2011, Jackman and Kandarian 2004], irisin [Huh et al. 2014, Planella-Farrugia et al.
2019, Lee and Jun 2019] and its precursor fibronectin type III domain containing 5 (Fndc5)
[Bubak et al. 2017], Follistatin (Fst) [Brooks and Myburgh 2014, Sepulveda et al. 2015]; and
additional bone biomarkers: osteocalcin (Bglap), collagen type 1 alpha 1 (Col1a1) runt-related
transcription factor 2 (Runx2), sclerostin (Scl), cathepsin K (CatK), tartrate resistant acid
phosphatase type 5 (Acp5), receptor activator of nuclear kappa-B ligand (RANKL),
osteoprotegerin (OPG), Tartrate-resistant acid phosphatase (Tracp), Interleukin-1 alpha and
beta (Il1α and Il1B), Interleukin-6 (Il6), alkaline phosphatase, low-density lipoprotein receptorrelated protein 5 (Lrp5), and secreted frizzled related protein 2 (Sfrp2) [Vegger et al. 2016,
Marchand-Libouban et al. 2013].
In conclusion, in this one-week study, skeletally mature Sprague-Dawley rats injected
with Botox showed a significant gait impairment when compared to saline-injected control
rats (~75% decreased gait ability). In addition, a new assessment technique was incorporated,
where the rats’ digit abduction and the reduction of this ability were observed. While rat
digit and gait ability were reduced, the BTX-injected rats had partial weight bearing in their
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injected limbs, possibly explaining why some of the subsequent analyses either showed few or
no significant differences when compared to CTRL. In weighing the quadriceps and calf
muscles of the rats, the muscular atrophy of the right leg muscles of the Botox-injected rats
were significantly smaller than that of the CTRL group, even after only one week (>20%).
Immunohistochemical analyses were also completed, although there were only a few
significant differences in localized osteocyte activity, and no differences in mast cells. The
qPCR technique was completely new to this lab, and four musculoskeletal-related genes of
interest were identified for this study. The muscle relative genetic expression analysis showed
increased expression of myostatin in BTX left versus BTX right (injected) and both CTRL legs,
indicating a potential systemic effect of Botox and/or disuse. Further analyses at additional
time points will help to understand the mechanism of bone degradation due to partial muscle
paralysis.
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